Authors:
VANLAAR F
DEVOS D
VANOPPEN D
SELS B
JACOBS PA
DELGUERZO A
PIERARD F
KIRSCHDEMESMAEKER A
Citation: F. Vanlaar et al., HETEROGENEOUS MOLYBDATE CATALYSTS FOR THE GENERATION OF SINGLET MOLECULAR-OXYGEN ((1)DELTA(G)) FROM H2O2, Chemical communications, (2), 1998, pp. 267-268
Authors:
VINKVANWIJNGAARDEN T
BLOMROSS ME
LANSDORP D
GOEDHART DM
EELHART J
GUELEN PJM
DEVOS D
Citation: T. Vinkvanwijngaarden et al., CLINICAL EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE INHALATION CAPSULES INHALED BY CYCLOHALER COMPARED WITH BECOTIDE ROTACAPS INHALED BY ROTAHALER, International journal of clinical pharmacology and therapeutics, 36(9), 1998, pp. 510-515
Citation: Dc. Vanbeelen et al., AROMATIC LEAD(IV) COMPOUNDS PART XV - SYNTHESIS AND MULTINUCLEAR NMR PROPERTIES OF COMPOUNDS OF THE (C6H5)(3)PBR (R = ALKYL, ALKENYL, ALKYNYL), Silicon, germanium, tin and lead compounds, 21(1), 1998, pp. 55-64
Citation: D. Devos et al., SERUM AND URINE LEVELS OF TAMOXIFEN AND ITS METABOLITES IN PATIENTS WITH ADVANCED BREAST-CANCER AFTER A LOADING DOSE AND AT STEADY-STATE LEVELS, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 512-514
Authors:
LIM A
DEVOS D
BRAUNS M
MOSSIALOS D
GABALLA A
QING D
CORNELIS P
Citation: A. Lim et al., MOLECULAR AND IMMUNOLOGICAL CHARACTERIZATION OF OPRL, THE 18 KDA OUTER-MEMBRANE PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN (PAL) OF PSEUDOMONAS-AERUGINOSA, Microbiology, 143, 1997, pp. 1709-1716
Authors:
MEYER JM
STINTZI A
DEVOS D
CORNELIS P
TAPPE R
TARAZ K
BUDZIKIEWICZ H
Citation: Jm. Meyer et al., USE OF SIDEROPHORES TO TYPE PSEUDOMONADS - THE 3 PSEUDOMONAS-AERUGINOSA PYOVERDINE SYSTEMS, Microbiology, 143, 1997, pp. 35-43
Authors:
LEYS D
LUCAS C
DEVOS D
MOUNIERVEHIER F
GODEFROY O
PRUVO JP
LESTAVEL P
BONFILS C
CAPARROSLEFEBVRE D
DAEMSMONTPEURT C
DEFEBVRE L
DEKLUNDER G
DELALANDE I
DURIEU I
GAUTIER C
GOLDSTEIN P
GOULLARD L
GUEROUAOU D
HAMON M
LECLERC X
LEDUC V
PASQUIER F
PERTUZON B
ROGELET P
SAVOYE C
SOTOARES G
VERMERSCH P
Citation: D. Leys et al., MISDIAGNOSES IN 1,250 CONSECUTIVE PATIENTS ADMITTED TO AN ACUTE STROKE UNIT, Cerebrovascular diseases, 7(5), 1997, pp. 284-288
Authors:
KANTARJIAN HM
OBRIEN SM
KEATING M
BERAN M
ESTEY E
GIRALT S
KORNBLAU S
RIOS MB
DEVOS D
TALPAZ M
Citation: Hm. Kantarjian et al., RESULTS OF DECITABINE THERAPY IN THE ACCELERATED AND BLASTIC PHASES OF CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 11(10), 1997, pp. 1617-1620
Authors:
WILLEM R
DALIL H
BROEKAERT P
BIESEMANS M
GHYS L
NOOTER K
DEVOS D
RIBOT F
GIELEN M
Citation: R. Willem et al., DI-N-BUTYLTIN, TRI-N-BUTYLTIN, AND TRIPHENYLTIN STEROIDCARBOXYLATES -SYNTHESIS, NMR CHARACTERIZATION AND IN-VITRO ANTITUMOR-ACTIVITY, Silicon, germanium, tin and lead compounds, 20(8), 1997, pp. 535-542
Authors:
VANBEELEN DC
VANRIJN J
HERINGA KD
WOLTERS J
DEVOS D
Citation: Dc. Vanbeelen et al., CYCLIC ORGANOLEAD COMPOUNDS .4. SYNTHESIS AND MULTINUCLEAR NMR PROPERTIES OF 6-MEMBERED HETEROCYCLIC ORGANOLEAD COMPOUNDS, Silicon, germanium, tin and lead compounds, 20(1), 1997, pp. 37-45
Authors:
DEVOS D
LIM A
PIRNAY JP
DUINSLAEGER L
REVETS H
VANDERKELEN A
HAMERS R
CORNELIS P
Citation: D. Devos et al., ANALYSIS OF EPIDEMIC PSEUDOMONAS-AERUGINOSA ISOLATES BY ISOELECTRIC-FOCUSING OF PYOVERDINE AND RAPD-PCR - MODERN TOOLS FOR AN INTEGRATED ANTI-NOSOCOMIAL INFECTION STRATEGY IN BURN WOUND CENTERS, Burns, 23(5), 1997, pp. 379-386
Authors:
NATH M
YADAV R
GIELEN M
DALIL H
DEVOS D
ENG G
Citation: M. Nath et al., SYNTHESIS, CHARACTERISTIC SPECTRAL STUDIES AND IN-VITRO ANTIMICROBIALAND ANTITUMOR ACTIVITIES OF ORGANOTIN(IV) COMPLEXES OF SCHIFF-BASES DERIVED FROM AMINO-ACIDS, Applied organometallic chemistry, 11(9), 1997, pp. 727-736
Authors:
DEVOS D
LIM A
PIRNAY JP
STRUELENS M
VANDENVELDE C
DUINSLAEGER L
VANDERKELEN A
CORNELIS P
Citation: D. Devos et al., DIRECT-DETECTION AND IDENTIFICATION OF PSEUDOMONAS-AERUGINOSA IN CLINICAL-SAMPLES SUCH AS SKIN BIOPSY SPECIMENS AND EXPECTORATIONS BY MULTIPLEX PCR BASED ON 2 OUTER-MEMBRANE LIPOPROTEIN GENES, OPRI AND OPRL, Journal of clinical microbiology, 35(6), 1997, pp. 1295-1299
Citation: Hp. Wijnand et D. Devos, ON SAMPLE SIZES FOR BIOEQUIVALENCE STUDIES WITH INHALED CORTICOSTEROIDS, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 325-327
Authors:
WILLEM R
BOUHDID A
MAHIEU B
GHYS L
BIESEMANS M
TIEKINK ERT
DEVOS D
GIELEN M
Citation: R. Willem et al., SYNTHESIS, CHARACTERIZATION AND IN-VITRO ANTITUMOR-ACTIVITY OF TRIPHENYLTIN AND TRI-N-BUTYLTIN BENZOATES, PHENYLACETATES AND CINNAMATES, Journal of organometallic chemistry, 531(1-2), 1997, pp. 151-158
Citation: D. Devos et T. Bein, INTRAZEOLITE COMPLEXATION OF TRANSITION-METAL IONS BY TRIAZACYCLONONANE-TYPE LIGANDS - CONTROL OF CLUSTER NUCLEARITY AND OXYGEN-BINDING IN CONFINED REACTION SPACES, Journal of the American Chemical Society, 119(40), 1997, pp. 9460-9465
Citation: D. Devos et al., INVESTIGATION OF THE ROLE OF L-LACTATE DEHYDROGENASE THR246 - STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF THE T246W MUTANT, Archives of physiology and biochemistry, 104(3), 1996, pp. 40-40
Citation: D. Devos et T. Bein, HIGHLY SELECTIVE EPOXIDATION OF ALKENES AND STYRENES WITH H2O2 AND MANGANESE COMPLEXES OF THE CYCLIC TRIAMINE 1,4,7-TRIMETHYL-1,4,7-TRIAZACYCLONONANE, Chemical communications, (8), 1996, pp. 917-918
Authors:
GIELEN M
WILLEM R
BOUHDID A
DEVOS D
KUIPER CM
VEERMAN G
PETERS GJ
Citation: M. Gielen et al., IN-VITRO ANTIPROLIFERATIVE EFFECTS, TOXICITY PROFILES IN-VIVO IN MICEAND ANTITUMOR-ACTIVITY IN TUMOR-BEARING MICE OF 4 DIORGANOTIN COMPOUNDS, Oncology Reports, 3(3), 1996, pp. 583-587
Authors:
WILLEM R
BOUHDID A
BIESEMANS M
MARTINS JC
DEVOS D
TIEKINK ERT
GIELEN M
Citation: R. Willem et al., SYNTHESIS AND CHARACTERIZATION OF TRIPHENYLTIN AND TRI-N-BUTYLTIN PENTAFLUOROBENZOATES, PENTAPHENYLACETATES AND PENTACINNAMATES - X-RAY STRUCTURE DETERMINATION OF TRI-N-BUTYLTIN PENTAFLUOROCINNAMATE, Journal of organometallic chemistry, 514(1-2), 1996, pp. 203-212
Authors:
KANTARJIAN H
OBRIEN S
BERAN M
GIRALT S
ESTEY E
KOLLER C
KORNBLAU S
ANDREEFF M
DEVOS D
KEATING M
TALPAZ M
Citation: H. Kantarjian et al., RESULTS WITH DECITABINE, A HYPOMETHYLATING AGENT, IN THE TREATMENT OFCHRONIC MYELOGENOUS LEUKEMIA (CML) IN ACCELERATED OR ELASTIC PHASES, Blood, 88(10), 1996, pp. 3522-3522